Valsartan/Lercanidipine Hydrochloride

缬沙坦/盐酸乐卡地平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameValsartan/Lercanidipine Hydrochloride
Drug Alias NameValsartan/lercanidipine盐酸乐卡地平/缬沙坦Lercanidipine Hydrochloride/ValsartanValsartan and Lercanidipine HydrochlorideLercanidipine/Valsartan +[6] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsEssential Hypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2013/07/01
Country/TerritorySouth Korea
CombinationsYes ValsartanLercanidipine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLg Chemical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLg Chemical Ltd
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DB08
Related LinksN/A